According to ASSOCHAM, with a consecutive CAGR of 35.1%, the Biotech sector is expected to grow to US$ 5 billion by 2009-10. Accounting
for 52% of the industry's total revenue, Biotech sector exports are valued at US$ 763 million. With a growth rate of 36%, the investments in the sector have grown to US$ 360 million in 2005-06. Currently, there are more than 300 biotech companies focusing on different aspects of value chain and this figure is expected to double in the next 3-4 years.
With a growth rate of 32%, Biopharma sector has grown to US$ 1 billion in 2005-06. It accounts for over 70% of domestic sales and 75% of total exports. Agri Biotech and BioServices are registering fastest growth and Vaccines and
|